Ruby Chen-Tsai

Chief Executive Officer/President/Co - founder at Applied StemCell, Inc. - Milpitas, CA, US

Ruby Chen-Tsai's Colleagues at Applied StemCell, Inc.
Kai Wang

Scientific Program Manager, Animal Group Head, Senior Scientist | Genome Editing/Therapeutics

Contact Kai Wang

Jinling Li

SVP, Scientific Alliances

Contact Jinling Li

Hainan Chen

Director of Genome Technology Core

Contact Hainan Chen

Alexander Wu

Team Leader / Project Manager

Contact Alexander Wu

Jane Li

Scientific Project Manager

Contact Jane Li

Devi B

Project Manager

Contact Devi B

View All Ruby Chen-Tsai's Colleagues
Ruby Chen-Tsai's Contact Details
HQ
408-773-8007
Location
Company
Applied StemCell, Inc.
Ruby Chen-Tsai's Company Details
Applied StemCell, Inc. logo, Applied StemCell, Inc. contact details

Applied StemCell, Inc.

Milpitas, CA, US • 100 - 249 Employees
BioTech/Drugs

Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered in Milpitas, California. Our goal is to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry. After years of research and development, ASC is proud to offer an optimized series of tools for basic research study, drug discovery, bio-processing, bio-production and preclinical applications.We are currently focusing on three areas: (1) cell line generation for bio-production and bioassays (2) patient-relevant cell models for personalized medicine and (3) physiologically predictive animal models of human diseases. We are striving to improve and expand our technologies and product lines to meet the increasing requirements of the biomedical community. • Stem Cells & Cell Line Models• Mouse Model Generation• AAV Potency Assay • Antibody Discovery & Screening• Bioproduction • Regenerative Medicine• Pre-IND Filing Consultation Using our TARGATT™ technology, a gene-of-interest can be specifically inserted at a well-characterized, transcriptionally active locus in the genome with guaranteed transgene expression. This site-specific Knock-in technology has been first established in mouse models, and we have successfully applied it to human cell lines. We are moving forward to various projects that will combine the CRISPR/Cas9 technology and TARGATT™ for highly specified transgene expression.For patent licensing, business development, and investment inquiries, please contact us at info@appliedstemcell.com.

Genome Editing Mouse Rat Model Generation Cell Line Models iPSC Disease Modeling iPSC Differentiation iPSC Tox Study iPSC Generation Reference Standards Isogenic Cell Lines Phonetype Screening FFPE Contract Research Stem Cell Culture Bioproduction CRISPR/Cas9 Cancer Research Neuro Disease Research Genomics Virus Packaging Safe Harbor Locus antibody production Antibody screening antibody discovery B2B Biotech SaaS Commercial Physical Research Biotechnology Biotech Pharmaceuticals
Details about Applied StemCell, Inc.
Frequently Asked Questions about Ruby Chen-Tsai
Ruby Chen-Tsai currently works for Applied StemCell.
Ruby Chen-Tsai's role at Applied StemCell is Chief Executive Officer/President/Co - founder.
Ruby Chen-Tsai's email address is ***@appliedstemcell.com. To view Ruby Chen-Tsai's full email address, please signup to ConnectPlex.
Ruby Chen-Tsai works in the Biotechnology industry.
Ruby Chen-Tsai's colleagues at Applied StemCell, Inc. are Kai Wang, Jinling Li, Hainan Chen, Alexander Wu, Simran Kaur, Jane Li, Devi B and others.
Ruby Chen-Tsai's phone number is 408-773-8007
See more information about Ruby Chen-Tsai